Solve Therapeutics
PrivateLast Round
VC Round
Nov 17, 2025
Total Funding Raised
$126M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Solve Therapeutics is a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) and a novel diagnostic platform for solid tumor malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solve Therapeutics Comparables
Compare Solve Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adcentrx Therapeutics | 88% | |
| Ona Therapeutics | 83% | |
| Duality Biotherapeutics Inc | 77% |
Solve Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 17, 2025 | ||||
| VC Round | Dec 26, 2024 | ||||
| Series A | Dec 14, 2022 |
Solve Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | VC Round, Series A |
| SymBiosis Capital Management | VC Round |
| Balyasny Asset Management L.P. | VC Round |
| B Capital Group | VC Round |
| Ally Bridge Group | VC Round |
| DC Ventures | VC Round |
| Abingworth | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
$120M raised in early funding.
- Dec 26, 2024
$75M raised with participation from General Atlantic and Citadel.
Solve Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Solve Therapeutics's valuation, stock price, and market status.
Is Solve Therapeutics a public or private company?
Solve Therapeutics is a private company.
What is the current stock price of Solve Therapeutics?
Solve Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Solve Therapeutics worth (valuation)?
Valuation information for Solve Therapeutics is not publicly available.
Can I buy Solve Therapeutics stock?
Solve Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Solve Therapeutics's last funding round?
Solve Therapeutics's most recent funding round was Early Funding on November 17, 2025.
Who are the main investors in Solve Therapeutics?
Key investors in Solve Therapeutics include Yosemite.
Will Solve Therapeutics IPO soon?
No public IPO plans have been announced for Solve Therapeutics.
How can I track Solve Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Solve Therapeutics's secondary market activity and sign up for updates.